European Journal of Internal Medicine
Volume 19, Issue 2 , Pages 129-134, March 2008

Excessive prolongation of prothrombin time among patients treated with warfarin and admitted to the emergency room

  • George Habib

      Affiliations

    • Department of Medicine, Carmel Medical Center, Faculty of Medicine, Technion, Isreal Institute of Technology, Haifa, Israel
    • Corresponding Author InformationCorresponding author. Department of Medicine, Carmel Medical Center, Haifa 34362, Israel.
  • ,
  • Munir Nashashibi

      Affiliations

    • Department of Pathology, Carmel Medical Center, Haifa, Israel
  • ,
  • Arin Khateeb

      Affiliations

    • Pharmacy unit, Carmel Medical Center, Haifa, Israel
  • ,
  • Sharon Goichman

      Affiliations

    • Nutrition unit, Carmel Medical Center, Haifa, Israel
  • ,
  • Asia Kogan

      Affiliations

    • Emergency Room, Carmel Medical Center, Haifa, Israel

Received 22 January 2007; received in revised form 17 August 2007; accepted 30 August 2007. published online 10 December 2007.

Abstract 

Introduction

Patients treated with warfarin are uncommonly admitted with excessive prolongation of international normalized ratio (INR) of prothrombin time (PT) to the emergency room (ER). Here we wanted to evaluate the reasons behind this prolongation, clinical and laboratory parameters, course and outcome of these patients.

Patients and methods

Consecutive patients admitted to the ER with prolonged PT-INR>6 under warfarin treatment and who gave sufficient information regarding history of warfarin treatment, were followed prospectively. Patients or care-givers were asked about warfarin treatment, PT monitoring, current and new medications especially antibiotics and diet. Clinical and laboratory parameters, course and outcome were also documented. Age and gender matched patients with therapeutic INR level were used as a control group.

Results

75 patients finished the study. The median INR level among the patients was 8.5 and a range of 6.1–59.5. The median duration of warfarin treatment was 12 months among the patients vs. 36 in the control group, p<0.001 and family physician was the sole decider on warfarin dose in 71 patients vs. 49 in the control group, p<0.100. 19 patients adhered to balanced diet vs. 34 in the control group, p=0.01. Dose increment of warfarin was the most common definite cause of prolonged PT followed by adding new medication especially amiodarone and recently started warfarin. Significantly more patients had evidence of bleeding than the control group but no difference in mean hemoglobin level or number of patients transfused with packed cells. No difference in the number of patients hospitalized or duration of hospitalization, but 5 in-hospital fatalities in the patients' group vs. none in the control group.

Conclusion

Excessive PT prolongation is mainly due to warfarin dose increment, adding new medication especially amiodarone and recently started warfarin. It is significantly more associated with bleeding and higher in-hospital mortality.

Keywords: Prolongation, Prothrombin time, Warfarin

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0953-6205(07)00261-0

doi:10.1016/j.ejim.2007.08.006

European Journal of Internal Medicine
Volume 19, Issue 2 , Pages 129-134, March 2008